← Leaderboards
Kendall R Van Keuren-Jensen
Translational Genomics Research Inst
$3,951,101
Attributed
$11,498,424
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,498,424 · 7
By mechanism
UH3$6,675,478 · 3
R01$2,520,102 · 1
UG3$1,712,419 · 2
UH2$590,425 · 1
Top collaborators
- P. David Adelson7 shared
- Matt Huentelman7 shared
- Yashar Kalani7 shared
- Saumya Das4 shared
- Bogdan Mateescu4 shared
- Robert Raffai4 shared
- Rita Sattler4 shared
- Tijana Talisman4 shared
Most similar at Translational Genomics Research Inst
Same institution · by research overlap
- Matt Huentelman$25,001,101
- Yashar Kalani$905,174
- Robert Spetzler$166,667
Others in their field
Top investigators on “Validation”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$515,091,456
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- David Heimbrook · Leidos Biomedical Research, Inc.$239,311,963
Research focus
ValidationBiological MarkersInnovationMicrornasBrainPlasmaExtracellularTissuesTranscriptome SequencingCellsProteinsLeadCollaborationsCollectionSamplingPrognostic MarkerSensitivity And SpecificityBloodDetectionImageSmall RnaDiagnosticBaseAlzheimer&Apos
Grant awards (19)
Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD$788,244
R01 · FY2025 · NS
Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD$64,322
R01 · FY2025 · NS
Molecular dissection and imaging of extracellular vesicles to define their origin and targets$1,100,398
UH3 · FY2022 · TR
Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD$831,382
R01 · FY2022 · NS
P.R.I.S.M: Purification of exRNA by Immuno-capture and Sorting using Microfluidic$725,835
UH3 · FY2022 · CA
Molecular dissection and imaging of extracellular vesicles to define their origin and targets$1,100,083
UH3 · FY2021 · TR
Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD$836,154
R01 · FY2021 · NS
P.R.I.S.M: Purification of exRNA by Immuno-capture and Sorting using Microfluidic$718,893
UH3 · FY2021 · CA
Molecular dissection and imaging of extracellular vesicles to define their origin and targets$454,882
UG3 · FY2020 · TR
P.R.I.S.M: Purification of exRNA by Immuno-capture and Sorting using Microfluidic$374,384
UG3 · FY2020 · CA
Molecular dissection and imaging of extracellular vesicles to define their origin and targets$483,679
UG3 · FY2019 · TR
P.R.I.S.M: Purification of exRNA by Immuno-capture and Sorting using Microfluidic$399,474
UG3 · FY2019 · CA
exRNA signatures Predict Outcomes after brain injury$937,024
UH3 · FY2017 · TR · contact PI
exRNA signatures Predict Outcomes after brain injury$90,222
UH3 · FY2017 · TR · contact PI
exRNA signatures Predict Outcomes after brain injury$948,972
UH3 · FY2016 · TR · contact PI
exRNA signatures Predict Outcomes after brain injury$961,051
UH3 · FY2015 · TR · contact PI
exRNA signatures Predict Outcomes after brain injury$93,000
UH3 · FY2015 · TR · contact PI
exRNA signatures Predict Outcomes after brain injury$497,425
UH2 · FY2014 · TR · contact PI
Optimization and Normalization Studies for CSF as a Biomarker$93,000
UH2 · FY2014 · TR · contact PI